Sodium-glucose Co-transporter 2 Inhibitors in acute heart failure: A review of the available evidence and practical guidance on clinical use.
28 Apr, 2022 | 08:15h | UTC
Commentary on Twitter
#RCM – Vol. 23 No. 4
?Review
Sodium-glucose Co-transporter 2 Inhibitors in Acute Heart Failure: A Review of the Available Evidence and Practical Guidance on Clinical Use#SGLT2Inhibitor #HeartFailureFulltext:https://t.co/Y997Js75GG pic.twitter.com/61gieE7Mcv
— Reviews in Cardiovascular Medicine (@RCMjournal) April 27, 2022